KEGG   PATHWAY: bta05140
Entry
bta05140                    Pathway                                
Name
Leishmaniasis - Bos taurus (cow)
Description
Leishmania is an intracellular protozoan parasite of macrophages that causes visceral, mucosal, and cutaneous diseases. The parasite is transmitted to humans by sandflies, where they survive and proliferate intracellularly by deactivating the macrophage. Successful infection of Leishmania is achieved by alteration of signaling events in the host cell, leading to enhanced production of the autoinhibitory molecules like TGF-beta and decreased induction of cytokines such as IL12 for protective immunity. Nitric oxide production is also inhibited. In addition, defective expression of major histocompatibility complex (MHC) genes silences subsequent T cell activation mediated by macrophages, resulting in abnormal immune responses.
Class
Human Diseases; Infectious disease: parasitic
Pathway map
bta05140  Leishmaniasis
bta05140

Disease
H00359  Leishmaniasis
Organism
Bos taurus (cow) [GN:bta]
Gene
100138386  CR1L; LOW QUALITY PROTEIN: complement component receptor 1-like protein [KO:K04011]
100300716  [KO:K06856]
100300806  [KO:K06856]
100848815  [KO:K06752]
104968484  [KO:K06856]
280677  C3; complement C3 preproprotein [KO:K03990]
280795  FOS; protein c-Fos [KO:K04379]
280824  IL4; interleukin-4 precursor [KO:K05430]
280831  JUN; transcription factor Jun [KO:K04448]
280943  TNF; tumor necrosis factor [KO:K03156]
281111  CYBA; cytochrome b-245 light chain [KO:K08009]
281112  CYBB; cytochrome b-245 heavy chain [KO:K21421] [EC:1.-.-.-]
281237  IFNG; interferon gamma precursor [KO:K04687]
281246  IL10; interleukin-10 precursor [KO:K05443]
281250  IL1A; interleukin-1 alpha precursor [KO:K04383]
281251  IL1B; interleukin-1 beta precursor [KO:K04519]
281345  NCF1; neutrophil cytosol factor 1 [KO:K08011]
281346  NCF2; neutrophil cytosol factor 2 [KO:K08010]
281534  TLR2; toll-like receptor 2 precursor [KO:K10159]
281536  TLR4; toll-like receptor 4 precursor [KO:K10160]
281766  FCGR3A; low affinity immunoglobulin gamma Fc region receptor III-A isoform 1 precursor [KO:K06463]
281856  IL12A; interleukin-12 subunit alpha precursor [KO:K05406]
281857  IL12B; interleukin-12 subunit beta precursor [KO:K05425]
281876  ITGB1; integrin beta-1 precursor [KO:K05719]
281877  ITGB2; integrin beta-2 precursor [KO:K06464]
282023  PTGS2; prostaglandin G/H synthase 2 precursor [KO:K11987] [EC:1.14.99.1]
282089  TGFB1; transforming growth factor beta-1 proprotein precursor [KO:K13375]
282220  EEF1A1; elongation factor 1-alpha 1 [KO:K03231]
282227  FCGR1A; high affinity immunoglobulin gamma Fc receptor I precursor [KO:K06498]
282291  NFKBIA; NF-kappa-B inhibitor alpha [KO:K04734]
282325  PRKCB; protein kinase C beta type [KO:K19662] [EC:2.7.11.13]
282490  BOLA-DMA; HLA class II histocompatibility antigen, DM alpha chain precursor [KO:K06752]
282491  BOLA-DMB; major histocompatibility complex, class II, DM beta precursor [KO:K06752]
282493  BOLA-DOB; HLA class II histocompatibility antigen, DO beta chain precursor [KO:K06752]
282494  BOLA-DQA5; major histocompatibility complex, class II, DQ alpha 5 precursor [KO:K06752]
282495  BOLA-DQB; major histocompatibility complex, class II, DQ beta precursor [KO:K06752]
282497  BOLA-DYA; major histocompatibility complex, class II, DY alpha precursor [KO:K06752]
282498  BOLA-DYB; major histocompatibility complex, class II, DY beta precursor [KO:K06752]
282530  BOLA-DRB3; major histocompatibility complex, class II, DRB3 [KO:K06752]
282535  BOLA-DQA2; major histocompatibility complex, class II, DQ alpha 2 [KO:K06752]
282876  NOS2; nitric oxide synthase, inducible [KO:K13241] [EC:1.14.13.39]
282882  ITGA4; integrin alpha-4 precursor [KO:K06483]
327672  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
407124  ITGAM; integrin alpha-M precursor [KO:K06461]
444881  MYD88; myeloid differentiation primary response protein MyD88 [KO:K04729]
506214  BOLA-DRA; major histocompatibility complex, class II, DR alpha precursor [KO:K06752]
507859  NCF4; neutrophil cytosol factor 4 [KO:K08012]
508233  RELA; transcription factor p65 [KO:K04735]
508619  IFNGR1; interferon gamma receptor 1 precursor [KO:K05132]
510814  STAT1; signal transducer and activator of transcription 1-alpha/beta [KO:K11220]
512312  PTPN6; tyrosine-protein phosphatase non-receptor type 6 [KO:K05697] [EC:3.1.3.48]
512943  MAPK12; mitogen-activated protein kinase 12 [KO:K04441] [EC:2.7.11.24]
514889  IFNGR2; interferon gamma receptor 2 isoform X1 [KO:K05133]
515233  EEF1A2; elongation factor 1-alpha 2 [KO:K03231]
519958  TAB1; TGF-beta-activated kinase 1 and MAP3K7-binding protein 1 [KO:K04403]
524810  [KO:K06856]
525246  JAK2; tyrosine-protein kinase JAK2 isoform X1 [KO:K04447] [EC:2.7.10.2]
525408  NFKBIB; NF-kappa-B inhibitor beta [KO:K02581]
525727  BOLA-DOA; HLA class II histocompatibility antigen, DO alpha chain precursor [KO:K06752]
529146  MAP3K7; mitogen-activated protein kinase kinase kinase 7 [KO:K04427] [EC:2.7.11.25]
531391  MAPK3; mitogen-activated protein kinase 3 [KO:K04371] [EC:2.7.11.24]
533692  IRAK4; interleukin-1 receptor-associated kinase 4 [KO:K04733] [EC:2.7.11.1]
533953  IRAK1; interleukin-1 receptor-associated kinase 1 [KO:K04730] [EC:2.7.11.1]
534069  TGFB2; transforming growth factor beta-2 proprotein precursor [KO:K13376]
534492  MAPK14; mitogen-activated protein kinase 14 [KO:K04441] [EC:2.7.11.24]
535327  MAPK13; mitogen-activated protein kinase 13 [KO:K04441] [EC:2.7.11.24]
537201  JAK1; tyrosine-protein kinase JAK1 [KO:K11217] [EC:2.7.10.2]
538700  BOLA-DRB2; HLA class II histocompatibility antigen, DR beta 5 chain isoform X3 [KO:K06752]
538957  TGFB3; transforming growth factor beta-3 proprotein [KO:K13377]
539124  TRAF6; TNF receptor-associated factor 6 [KO:K03175] [EC:2.3.2.27]
539241  BLA-DQB; boLa class II histocompatibility antigen, DQB*0101 beta chain precursor [KO:K06752]
539555  MARCKSL1; MARCKS-related protein [KO:K13536]
540203  TAB2; TGF-beta-activated kinase 1 and MAP3K7-binding protein 2 [KO:K04404]
616115  NFKB1; nuclear factor NF-kappa-B p105 subunit [KO:K02580]
618722  DSB; MHC class II antigen DS beta [KO:K06752]
618906  MAPK11; mitogen-activated protein kinase 11 [KO:K04441] [EC:2.7.11.24]
782032  [KO:K03175] [EC:2.3.2.27]
782652  FCGR2A; low affinity immunoglobulin gamma Fc region receptor II-a [KO:K06472]
786886  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
Compound
C00076  Calcium cation
C00195  N-Acylsphingosine
C00219  Arachidonate
C00533  Nitric oxide
C00584  Prostaglandin E2
C02737  Phosphatidylserine
Reference
  Authors
Cunningham AC
  Title
Parasitic adaptive mechanisms in infection by leishmania.
  Journal
Exp Mol Pathol 72:132-41 (2002)
DOI:10.1006/exmp.2002.2418
Reference
  Authors
Nandan D, Knutson KL, Lo R, Reiner NE
  Title
Exploitation of host cell signaling machinery: activation of macrophage phosphotyrosine phosphatases as a novel mechanism of molecular microbial pathogenesis.
  Journal
J Leukoc Biol 67:464-70 (2000)
DOI:10.1002/jlb.67.4.464
Reference
PMID:7591091
  Authors
Nandan D, Reiner NE
  Title
Attenuation of gamma interferon-induced tyrosine phosphorylation in mononuclear phagocytes infected with Leishmania donovani: selective inhibition of signaling through Janus kinases and Stat1.
  Journal
Infect Immun 63:4495-500 (1995)
DOI:10.1128/IAI.63.11.4495-4500.1995
Reference
  Authors
Nandan D, Lo R, Reiner NE
  Title
Activation of phosphotyrosine phosphatase activity attenuates mitogen-activated protein kinase signaling and inhibits c-FOS and nitric oxide synthase expression in macrophages infected with Leishmania donovani.
  Journal
Infect Immun 67:4055-63 (1999)
DOI:10.1128/IAI.67.8.4055-4063.1999
Reference
PMID:7916951
  Authors
Reiner NE
  Title
Altered cell signaling and mononuclear phagocyte deactivation during intracellular infection.
  Journal
Immunol Today 15:374-81 (1994)
DOI:10.1016/0167-5699(94)90176-7
Reference
  Authors
Nandan D, Reiner NE
  Title
Leishmania donovani engages in regulatory interference by targeting macrophage protein tyrosine phosphatase SHP-1.
  Journal
Clin Immunol 114:266-77 (2005)
DOI:10.1016/j.clim.2004.07.017
Reference
  Authors
Kima PE
  Title
The amastigote forms of Leishmania are experts at exploiting host cell processes to establish infection and persist.
  Journal
Int J Parasitol 37:1087-96 (2007)
DOI:10.1016/j.ijpara.2007.04.007
Reference
  Authors
Forget G, Gregory DJ, Olivier M
  Title
Proteasome-mediated degradation of STAT1alpha following infection of macrophages with Leishmania donovani.
  Journal
J Biol Chem 280:30542-9 (2005)
DOI:10.1074/jbc.M414126200
Reference
  Authors
Cameron P, McGachy A, Anderson M, Paul A, Coombs GH, Mottram JC, Alexander J, Plevin R
  Title
Inhibition of lipopolysaccharide-induced macrophage IL-12 production by Leishmania mexicana amastigotes: the role of cysteine peptidases and the NF-kappaB signaling pathway.
  Journal
J Immunol 173:3297-304 (2004)
DOI:10.4049/jimmunol.173.5.3297
Reference
  Authors
Tuon FF, Amato VS, Bacha HA, Almusawi T, Duarte MI, Amato Neto V
  Title
Toll-like receptors and leishmaniasis.
  Journal
Infect Immun 76:866-72 (2008)
DOI:10.1128/IAI.01090-07
Reference
  Authors
Kropf P, Freudenberg N, Kalis C, Modolell M, Herath S, Galanos C, Freudenberg M, Muller I
  Title
Infection of C57BL/10ScCr and C57BL/10ScNCr mice with Leishmania major reveals a role for Toll-like receptor 4 in the control of parasite replication.
  Journal
J Leukoc Biol 76:48-57 (2004)
DOI:10.1189/jlb.1003484
Reference
  Authors
Feng GJ, Goodridge HS, Harnett MM, Wei XQ, Nikolaev AV, Higson AP, Liew FY
  Title
Extracellular signal-related kinase (ERK) and p38 mitogen-activated protein (MAP) kinases differentially regulate the lipopolysaccharide-mediated induction of inducible nitric oxide synthase and IL-12 in macrophages: Leishmania phosphoglycans subvert macrophage IL-12 production by targeting ERK MAP kinase.
  Journal
J Immunol 163:6403-12 (1999)
Reference
  Authors
Olivier M, Gregory DJ, Forget G
  Title
Subversion mechanisms by which Leishmania parasites can escape the host immune response: a signaling point of view.
  Journal
Clin Microbiol Rev 18:293-305 (2005)
DOI:10.1128/CMR.18.2.293-305.2005
Reference
  Authors
Matte C, Maion G, Mourad W, Olivier M
  Title
Leishmania donovani-induced macrophages cyclooxygenase-2 and prostaglandin E2 synthesis.
  Journal
Parasite Immunol 23:177-84 (2001)
DOI:10.1046/j.1365-3024.2001.00372.x
Reference
  Authors
Ghosh S, Bhattacharyya S, Sirkar M, Sa GS, Das T, Majumdar D, Roy S, Majumdar S
  Title
Leishmania donovani suppresses activated protein 1 and NF-kappaB activation in host macrophages via ceramide generation: involvement of extracellular signal-regulated kinase.
  Journal
Infect Immun 70:6828-38 (2002)
DOI:10.1128/IAI.70.12.6828-6838.2002
Reference
PMID:9504340
  Authors
Bogdan C, Rollinghoff M
  Title
The immune response to Leishmania: mechanisms of parasite control and evasion.
  Journal
Int J Parasitol 28:121-34 (1998)
DOI:10.1016/S0020-7519(97)00169-0
Reference
  Authors
Blanchette J, Abu-Dayyeh I, Hassani K, Whitcombe L, Olivier M
  Title
Regulation of macrophage nitric oxide production by the protein tyrosine phosphatase Src homology 2 domain phosphotyrosine phosphatase 1 (SHP-1).
  Journal
Immunology 127:123-33 (2009)
DOI:10.1111/j.1365-2567.2008.02929.x
Reference
  Authors
Alexander J, Satoskar AR, Russell DG
  Title
Leishmania species: models of intracellular parasitism.
  Journal
J Cell Sci 112 Pt 18:2993-3002 (1999)
Reference
  Authors
Denkers EY, Butcher BA
  Title
Sabotage and exploitation in macrophages parasitized by intracellular protozoans.
  Journal
Trends Parasitol 21:35-41 (2005)
DOI:10.1016/j.pt.2004.10.004
Reference
  Authors
Lodge R, Diallo TO, Descoteaux A
  Title
Leishmania donovani lipophosphoglycan blocks NADPH oxidase assembly at the phagosome membrane.
  Journal
Cell Microbiol 8:1922-31 (2006)
DOI:10.1111/j.1462-5822.2006.00758.x
Reference
  Authors
de Freitas Balanco JM, Moreira ME, Bonomo A, Bozza PT, Amarante-Mendes G, Pirmez C, Barcinski MA
  Title
Apoptotic mimicry by an obligate intracellular parasite downregulates macrophage microbicidal activity.
  Journal
Curr Biol 11:1870-3 (2001)
DOI:10.1016/S0960-9822(01)00563-2
Reference
  Authors
Kane MM, Mosser DM
  Title
Leishmania parasites and their ploys to disrupt macrophage activation.
  Journal
Curr Opin Hematol 7:26-31 (2000)
DOI:10.1097/00062752-200001000-00006
Reference
  Authors
de Almeida MC, Vilhena V, Barral A, Barral-Netto M
  Title
Leishmanial infection: analysis of its first steps. A review.
  Journal
Mem Inst Oswaldo Cruz 98:861-70 (2003)
DOI:10.1590/S0074-02762003000700001
Related
pathway
bta00590  Arachidonic acid metabolism
bta04010  MAPK signaling pathway
bta04020  Calcium signaling pathway
bta04120  Ubiquitin mediated proteolysis
bta04145  Phagocytosis
bta04610  Complement and coagulation cascades
bta04620  Toll-like receptor signaling pathway
bta04630  JAK-STAT signaling pathway
bta04666  Fc gamma R-mediated phagosome formation
KO pathway
ko05140   

DBGET integrated database retrieval system